PFIZER INC

PFE · NYSE

Updated at 2026-10-14 09:38:55

$28.37-0.1%
Today's High
$28.61
Today’s Low
$28.13
PFIZER INC (PFE) Stock Price & Market Data
Search empty state illustration
...

Candlestick trends are for reference. Refer to the trading page for actual data.

Key Statistics

Previous Open
$28.42
Previous Close
$28.40
Volume
18.55M
Market Cap
$161.87B
P/E Ratio
37.32X
EPS
$0.75

Previous Day Range

$28.28$28.49

52-Week Range

$23.62$29.21

Company Overview

Sector
HEALTHCARE
Industry
Pharmaceuticals
Sub-industry
DRUG MANUFACTURERS - GENERAL
Headquarters
66 HUDSON BOULEVARD EAST, NEW YORK, NY, UNITED STATES, 10001-2192
Country
US
Listing Date
1944-01-17
Fiscal Year End
December
Shares Outstanding
5.69B
CIK
0000078003

Pfizer Inc. is an American multinational pharmaceutical and biotechnology corporation headquartered on 42nd Street in Manhattan, New York City. The name of the company commemorates its co-founder, Charles Pfizer (1824-1906). Pfizer develops and produces medicines and vaccines for immunology, oncology, cardiology, endocrinology, and neurology. The company has several blockbuster drugs or products that each generate more than 1 billion USD in annual revenues.

Financial Metrics

Revenue

2026-06-30

$15.03B

2026-03-31

$14.45B

2025-12-31

$17.55B

2025-09-30

$16.65B

Operating Expenses

2026-06-30

$6.23B

2026-03-31

$5.68B

2025-12-31

$8.59B

2025-09-30

$8.93B

Net Income

2026-06-30

-$246M

2026-03-31

$2.68B

2025-12-31

-$1.64B

2025-09-30

$3.54B

Net Profit Margin

2026-06-30

-1.63%

2026-03-31

18.6%

2025-12-31

-9.38%

2025-09-30

21.26%

Earnings Per Share

2026-06-30

$0.77

2026-03-31

$0.75

2025-12-31

$0.66

2025-09-30

$0.87

Earnings Before Interest, Taxes, Depreciation, and Amortization

2026-06-30

$1.63B

2026-03-31

$5.45B

2025-12-31

$756M

2025-09-30

$5.64B

Effective Tax Rate

2026-06-30

62.32%

2026-03-31

14.54%

2025-12-31

0.12%

2025-09-30

-6.47%

FAQs

Risk Warning

Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.